Donald Tashkin
Emeritus Professor of Medicine · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · ·
History
Pulmonary Disease
Internal Medicine
Research
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
New England Journal of Medicine · 2008 · First of 8 authors · Corresponding · 1,663 citations
Cyclophosphamide versus placebo in scleroderma lung disease
New England Journal of Medicine · 2006 · First of 32 authors · Corresponding · 1,231 citations
The Lancet Respiratory Medicine · 2016 · First of 45 authors · Corresponding · 831 citations
83 papers
50 papers
45 papers
45 papers
44 papers
41 papers
41 papers
40 papers
Grants
- 2009–2016
Sub Populations and Intermediate Outcomes Measures in Copd Study (Spiromics) - Clinical Center
National Heart, Lung, and Blood Institute · N01
Contact PI · $3.9M · Columbia University Health Sciences
- 2008–2015
National Heart, Lung, and Blood Institute · R01
Contact PI · $2M · University of California Los Angeles
- 2005–2010
Distal Lung Inflammation Effect on Asthma Exacerbations
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.1M · University of California Los Angeles
- 2004–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $15.1K · University of California Los Angeles
Clinical trials
- 2012–2013
Morbidity and Mortality Follow Up for the Scleroderma Lung Study
Principal investigator · Completed
Duke University
- 2009–2015
Principal investigator · Completed · Phase 2
Michael Roth
- 2008
Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD
Principal investigator · Completed · Phase 2
Chiesi Farmaceutici S.p.A.
- 2008–2009
Principal investigator · Withdrawn · Phase 4
University of California, Los Angeles